Medtronic Gears Up For FDA Panel With Mixed Results From AF Ablation Trial

Medtronic could face more questions than expected at an FDA advisory panel meeting later this month for the firm’s Phased RF Ablation System for atrial fibrillation due to mixed pivotal trial results released last week.